Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post, Danielle Eddy, Catherine Huntley, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244126-e0244126
Open Access | Times Cited: 341

Showing 26-50 of 341 citing articles:

Rapid detection of SARS-CoV-2: The gradual boom of lateral flow immunoassay
Jing He, Shuying Zhu, Jiawei Zhou, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 25
Severe Acute Respiratory Syndrome Coronavirus‐2
Patricia Slev
(2024), pp. 572-582
Closed Access | Times Cited: 8
Unleashing inkjet-printed nanostructured electrodes and battery-free potentiostat for the DNA-based multiplexed detection of SARS-CoV-2 genes
Marianna Rossetti, Chawin Srisomwat, Massimo Urban, et al.
Biosensors and Bioelectronics (2024) Vol. 250, pp. 116079-116079
Open Access | Times Cited: 7
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, et al.
JCI Insight (2021) Vol. 6, Iss. 17
Open Access | Times Cited: 49
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery
Maddalena Peghin, Maria De Martino, Martina Fabris, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 11
Open Access | Times Cited: 48
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada
Kate Zinszer, Britt McKinnon, Noémie Bourque, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2135975-e2135975
Open Access | Times Cited: 44
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design
Heinrich Scheiblauer, C. Micha Nübling, Timo Wolf, et al.
Journal of Clinical Virology (2021) Vol. 146, pp. 105052-105052
Open Access | Times Cited: 43
Role of ILC2 in Viral-Induced Lung Pathogenesis
Wendy Fonseca, Nicholas W. Lukacs, Srikanth Elesela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study
Maala Bhatt, Amy C. Plint, Ken Tang, et al.
CMAJ Open (2022) Vol. 10, Iss. 2, pp. E357-E366
Open Access | Times Cited: 28
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection
Rachel M. Gittelman, Enrico Lavezzo, Thomas M. Snyder, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 27
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 16
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19
Akhilesh Kumar Yadav, Nagaraj Basavegowda, Saba Shirin, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Lessons to be learned from test evaluations during the COVID-19 pandemic: RSS Working Group’s Report on Diagnostic Tests
Jonathan J Deeks, Deborah Ashby, Yemisi Takwoingi, et al.
Journal of the Royal Statistical Society Series A (Statistics in Society) (2024) Vol. 187, Iss. 3, pp. 659-709
Open Access | Times Cited: 5
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton, Marine Livrozet, Delphine Planas, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 6, pp. e1337-e1344
Open Access | Times Cited: 37
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
David J. McConnell, Conor Hickey, Norma Bargary, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4640-4640
Open Access | Times Cited: 34
Safety and immunogenicity of inactivated COVID‐19 vaccine in health care workers
Saovanee Benjamanukul, Sasiwimon Traiyan, Ritthideach Yorsaeng, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1442-1449
Open Access | Times Cited: 33
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020
Heather F. Gidding, Dorothy A. Machalek, Alexandra Hendry, et al.
The Medical Journal of Australia (2021) Vol. 214, Iss. 4, pp. 179-185
Open Access | Times Cited: 32
Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants
Xia Wang, Pu Yang, Junwen Zheng, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases
Javier Castillo‐Olivares, David A. Wells, Matteo Ferrari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32
COVID-19 serosurveys for public health decision making
Manoj Murhekar, Hannah Clapham
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e559-e560
Open Access | Times Cited: 32
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Enrico Lavezzo, Monia Pacenti, Laura Manuto, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 14
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Lucia Spicuzza, Davide Campagna, Chiara Di Maria, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 375-401
Open Access | Times Cited: 14

Scroll to top